![Determining breast cancer biomarker status and associated morphological features using deep learning | Communications Medicine Determining breast cancer biomarker status and associated morphological features using deep learning | Communications Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43856-021-00013-3/MediaObjects/43856_2021_13_Fig1_HTML.png)
Determining breast cancer biomarker status and associated morphological features using deep learning | Communications Medicine
![Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer | Experimental oncology Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer | Experimental oncology](http://exp-oncology.com.ua/wp/wp-content/uploads/2019/09/wpid-2633_fig_201_fmt.jpeg)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer | Experimental oncology
![Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1332ad61-1612-4599-87d3-f24b3014c44f/ijc33969-toc-0001-m.jpg)
Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library
![Current status of the prognostic molecular biomarkers in breast cancer: A systematic review (Review) Current status of the prognostic molecular biomarkers in breast cancer: A systematic review (Review)](https://www.spandidos-publications.com/article_images/ol/13/3/ol-13-03-1491-g00.jpg)
Current status of the prognostic molecular biomarkers in breast cancer: A systematic review (Review)
Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer | PLOS ONE
![PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/54ce5e0004d854229da124b4ed00755e2e2df55b/6-Table1-1.png)
PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar
![DNA methylation markers predict recurrence-free interval in triple-negative breast cancer | npj Breast Cancer DNA methylation markers predict recurrence-free interval in triple-negative breast cancer | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-020-0145-3/MediaObjects/41523_2020_145_Fig1_HTML.png)
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer | npj Breast Cancer
![Figures index : Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing Figures index : Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing](http://pubs.sciepub.com/jcrt/4/5/2/image/tab1.png)
Figures index : Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing
![Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419477612-gr1.jpg)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect
![Immunophenotyping invasive breast cancer: paving the road for molecular imaging | BMC Cancer | Full Text Immunophenotyping invasive breast cancer: paving the road for molecular imaging | BMC Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2407-12-240/MediaObjects/12885_2012_Article_3232_Fig1_HTML.jpg)